rs181969865

Variant summary

Our verdict is Pathogenic. The variant received 15 ACMG points: 15P and 0B. PS3PM2PP3PP5_Very_Strong

The NM_005993.5(TBCD):​c.2314C>T​(p.Arg772Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000203 in 1,575,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV006103597: Published functional studies demonstrate decreased binding capacity to beta-tubulin, ARL2, and TBCE and diminished ability to rescue axonal and dendritic phenotypes (PMID:27666374)".

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 0 hom. )

Consequence

TBCD
NM_005993.5 missense

Scores

4
11
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 6.39

Publications

5 publications found
Variant links:
Genes affected
TBCD (HGNC:11581): (tubulin folding cofactor D) Cofactor D is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. [provided by RefSeq, Jul 2008]
TBCD Gene-Disease associations (from GenCC):
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 15 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV006103597: Published functional studies demonstrate decreased binding capacity to beta-tubulin, ARL2, and TBCE and diminished ability to rescue axonal and dendritic phenotypes (PMID: 27666374)
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.817
PP5
Variant 17-82924992-C-T is Pathogenic according to our data. Variant chr17-82924992-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 268167.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005993.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
NM_005993.5
MANE Select
c.2314C>Tp.Arg772Cys
missense
Exon 27 of 39NP_005984.3
TBCD
NM_001411101.1
c.2263C>Tp.Arg755Cys
missense
Exon 26 of 38NP_001398030.1A0A804HLI2
TBCD
NM_001411102.1
c.2233C>Tp.Arg745Cys
missense
Exon 26 of 38NP_001398031.1A0A804HJ32

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TBCD
ENST00000355528.9
TSL:1 MANE Select
c.2314C>Tp.Arg772Cys
missense
Exon 27 of 39ENSP00000347719.4Q9BTW9-1
TBCD
ENST00000571796.5
TSL:1
n.972C>T
non_coding_transcript_exon
Exon 12 of 17
TBCD
ENST00000576677.6
TSL:1
n.1443C>T
non_coding_transcript_exon
Exon 5 of 16

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152256
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000364
AC:
7
AN:
192252
AF XY:
0.0000485
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000348
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000492
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000211
AC:
30
AN:
1423434
Hom.:
0
Cov.:
31
AF XY:
0.0000241
AC XY:
17
AN XY:
704408
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32678
American (AMR)
AF:
0.0000252
AC:
1
AN:
39666
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25496
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37778
South Asian (SAS)
AF:
0.0000247
AC:
2
AN:
81044
European-Finnish (FIN)
AF:
0.0000197
AC:
1
AN:
50646
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5724
European-Non Finnish (NFE)
AF:
0.0000220
AC:
24
AN:
1091500
Other (OTH)
AF:
0.0000340
AC:
2
AN:
58902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152372
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41588
American (AMR)
AF:
0.00
AC:
0
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome (4)
3
-
-
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.24
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T
Eigen
Uncertain
0.31
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.20
D
MetaRNN
Pathogenic
0.82
D
MetaSVM
Uncertain
-0.27
T
MutationAssessor
Uncertain
2.9
M
PhyloP100
6.4
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-6.5
D
REVEL
Uncertain
0.62
Sift
Uncertain
0.017
D
Sift4G
Benign
0.065
T
Polyphen
0.97
D
Vest4
0.97
MVP
0.83
MPC
0.80
ClinPred
0.93
D
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.51
gMVP
0.71
Mutation Taster
=28/72
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181969865; hg19: chr17-80882868; COSMIC: COSV62798029; COSMIC: COSV62798029; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.